These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1794374)

  • 21.
    Waites KB; Crabb DM; Xiao L; Duffy LB
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years.
    De Francesco MA; Caracciolo S; Bonfanti C; Manca N
    J Infect Chemother; 2013 Aug; 19(4):621-7. PubMed ID: 23192735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
    Farkas B; Ostorházi E; Pónyai K; Tóth B; Adlan E; Párducz L; Marschalkó M; Kárpáti S; Rozgonyi F
    Orv Hetil; 2011 Oct; 152(42):1698-702. PubMed ID: 21979223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibacterial effect of niaoluqing oral liquid on clinical drug-resistant strains and different serotype strains of Ureaplasma urealyticum in vitro].
    Lu Y; Chen DC; Li Q; Xuan GW; Fan BJ; Zhao JW; Wang N
    Zhonghua Nan Ke Xue; 2002; 8(2):152-4. PubMed ID: 12479037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of tylosin and its derivatives against Ureaplasma urealyticum.
    Zuzulova M; Kleinova D; Proksa B; Fuska J
    Arzneimittelforschung; 1995 Nov; 45(11):1222-4. PubMed ID: 8929244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae.
    Arai S; Gohara Y; Kuwano K; Kawashima T
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1322-4. PubMed ID: 1416832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli.
    Burridge R; Warren C; Phillips I
    J Antimicrob Chemother; 1986 Mar; 17(3):315-21. PubMed ID: 3084440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Ureaplasma urealyticum to ten chemotherapeutic agents.
    Sobetzko R; Hartmann AA; Elsner P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):245-50. PubMed ID: 2973712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones.
    Sánchez JE; Sáenz NG; Rincón MR; Martín IT; Sánchez EG; Martínez MJ
    J Antimicrob Chemother; 2000 Aug; 46(2):283-5. PubMed ID: 10933654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis.
    Vargović M; Pasini M; Papić N; Andrašević S; Markotić A; Butić I; Škerk V
    Sex Transm Infect; 2014 Feb; 90(1):69. PubMed ID: 24366778
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.
    Wang QY; Li RH; Zheng LQ; Shang XH
    J Microbiol Immunol Infect; 2016 Jun; 49(3):359-62. PubMed ID: 25081985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum.
    Dongya M; Wencheng X; Xiaobo M; Lu W
    Microb Drug Resist; 2008 Sep; 14(3):183-6. PubMed ID: 18707551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum.
    Dósa E; Nagy E; Falk W; Szöke I; Ballies U
    J Antimicrob Chemother; 1999 Apr; 43(4):575-8. PubMed ID: 10350390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.
    Schneider SC; Tinguely R; Droz S; Hilty M; Donà V; Bodmer T; Endimiani A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6026-31. PubMed ID: 26195516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in-vitro antibiotic susceptibility of Chlamydia pneumoniae.
    Fenelon LE; Mumtaz G; Ridgway GL
    J Antimicrob Chemother; 1990 Dec; 26(6):763-7. PubMed ID: 2081718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of tetracycline and macrolide-lincosamide-streptogramin B resistance genes in anaerobic bacteria.
    Roberts MC
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S367-9. PubMed ID: 7548600
    [No Abstract]   [Full Text] [Related]  

  • 38. Ureaplasma urealyticum and Ureaplasma parvum in women of reproductive age.
    Hunjak B; Sabol I; Vojnović G; Fistonić I; Erceg AB; Peršić Z; Grce M
    Arch Gynecol Obstet; 2014 Feb; 289(2):407-12. PubMed ID: 23912532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
    Soriano F
    Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
    Hannan PC; Woodnutt G
    J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.